RNA-directed DNA cleavage by the Cas9-crRNA complex

US11555187B2 · kind B2 · utility

Assignee

• Vilnius University · LT

Inventors

• Virginijus {hacek over (S)}ik{hacek over (s)}nys · Vilnius, LT
• Giedrius Gasiunas · Vilnius, LT
• Tautvydas Karvelis · Paberžė, LT
• Arvydas Lubys · Vilnius, LT
• Lolita Zaliauskiene · Vilnius, LT
• Monika Gasiuniene · Vilnius, LT
• Anja Smith · Thornton, US

Key dates

• Filing date: Dec 7, 2017
• Grant date: Jan 17, 2023
• Expiry date: Dec 7, 2037

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2800/80
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

Isolation or in vitro assembly of the Cas9-crRNA complex of the Streptococcus thermophilus CRISPR3/Cas system and use for cleavage of DNA bearing a nucleotide sequence complementary to the crRNA and a proto-spacer adjacent motif. Methods for site-specific modification of a target DNA molecule in vitro or in vivo using an RNA-guided DNA endonuclease comprising RNA sequences and at least one of an RuvC active site motif and an HNH active site motif; for conversion of Cas9 polypeptide into a nickase cleaving one strand of double-stranded DNA by inactivating one of the active sites (RuvC or HNH) in the polypeptide by at least one point mutation; for assembly of active polypeptide-polyribonucleotides complex in vivo or in vitro; and for re-programming a Cas9-crRNA complex specificity in vitro and using a cassette containing a single repeat-spacer-repeat unit.